Tobradex BID Compared to TOBRADEX and TOBREX/Vehicle

• Status: Withdrawn
• Trial end date: 2006-12-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to compare the new formulation of Tobradex to the current approved formulation

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Alcon Research
• Treatments: Anti-Bacterial Agents; Tobramycin, Dexamethasone Drug Combination

Criteria

Inclusion Criteria:

• Patients scheduled for cataract extraction

Exclusion Criteria:

• Under 18 years